These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2149110)

  • 1. [Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
    Inzitari D; Fratiglioni L; Baldereschi M; Candelise L; Anzalone N; Bonatti ML; Prencipe M; Gandolfo C; Mamoli A; Rasura M
    Epidemiol Prev; 1990 Jun; 12(43):6-11. PubMed ID: 2149110
    [No Abstract]   [Full Text] [Related]  

  • 2. Current therapy of cerebrovascular disease.
    Wilkerson RJ; Liem PH; Carter WJ
    J Ark Med Soc; 1984 Apr; 80(11):539-45. PubMed ID: 6234289
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
    Ostendorf P
    Internist (Berl); 1979 Nov; 20(11):539-46. PubMed ID: 396265
    [No Abstract]   [Full Text] [Related]  

  • 4. Does aspirin prevent stroke?
    Mitchell JR
    Practitioner; 1979 Nov; 223(1337):668-72. PubMed ID: 394138
    [No Abstract]   [Full Text] [Related]  

  • 5. [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke].
    Brechter C; Bäcklund H; Krook H; Müller R; Nitelius E; Olsson JE; Olsson O; Thornberg A
    Lakartidningen; 1980 Dec; 77(52):4947-56. PubMed ID: 7010029
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebrovascular disease.
    Warlow CP
    Clin Haematol; 1981 Jun; 10(2):631-51. PubMed ID: 7032789
    [No Abstract]   [Full Text] [Related]  

  • 7. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 9. Address of the president-elect: the indication for various methods of treatment of occlusive cerebrovascular disease.
    Millikan CH
    Trans Am Neurol Assoc; 1973; 98():206-18. PubMed ID: 4784937
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin in transient ischemic attacks and minor stroke: a meta-analysis.
    Stachenko SJ; Bravo G; Côté R; Boucher J; Battista RN
    Fam Pract Res J; 1991 Jun; 11(2):179-91. PubMed ID: 1829313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preventive drug therapy of transient cerebral ischemic attacks].
    Sørensen PS; Marquardsen J
    Ugeskr Laeger; 1982 Aug; 144(32):2357-60. PubMed ID: 7147462
    [No Abstract]   [Full Text] [Related]  

  • 13. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
    Friedman LM
    Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
    Passamani ER
    Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues.
    Gent M; Barnett HJ; Sackett DL; Taylor DW
    Circulation; 1980 Dec; 62(6 Pt 2):V97-105. PubMed ID: 7002357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transient cerebral ischemic attacks. Treatment program and comparison between anticoagulants and thrombocyte aggregation repressors].
    Burén A; Ygge J
    Lakartidningen; 1979 Aug; 76(34):2784-7. PubMed ID: 529907
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
    Bousser MG
    J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 20. A critical appraisal of the clinical efficiency of anti-platelet drugs.
    Lecompte T; Samama M
    Agents Actions Suppl; 1986; 20():203-14. PubMed ID: 3544741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.